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Abstract 
Background: Coronary artery disease is the most common type of heart disease. CAD encompasses 
atherosclerosis and arteriosclerosis and is the leading cause of death in the United States in both men 
and women. This disease process involves the blood vessels responsible for supplying blood to the heart. 
Arteriosclerosis is described as a hardening of the vessels, while atherosclerosis is the obstruction of 
vessels due to genetics and dietary/lifestyle activities. In the long-term, these abnormalities can lead to 
myocardial infarction (MI), valvular heart disease, chest pain or angina, and heart failure. 
Standard practice of care currently involves the use electrocardiogram (ECG), computed tomography (CT), 
and echocardiogram in order to monitor cardiac function. A new emerging imaging study, cardiac 
magnetic resonance with late gadolinium enhancement, has shown to be a promising prognostic tool in 
evaluating patient’s risks for major adverse coronary events (MACE). 
CMR is a medical imaging technology for non-invasive assessment for the function and structure of the 
heart. Gadolinium is a contrast agent that can be injected during the CMR study that localizes in cardiac 
cicatrix tissue. If the imaging study has a positive result, it may lend evidence that cardiac function is 
below optimal and may put patient at risk for MACE in the future. 
Methods: An exhaustive search of available medical literature was performed using the following 
databases: MEDLINE-OVID, MEDLINE-Pubmed, and CINAHL-EBSCO Host. Articles were discovered using 
the following terms: MRI, Coronary heart disease, gadolinium, LGE, and cicatrix. Relevant articles were 
assessed for quality using GRADE. 
Results: Three studies met the inclusion criteria and were included in this systematic review. All three of 
these cohort studies demonstrated that the presence of scar tissue, identified by late gadolinium 
enhancement (LGE), had a positive predictive value of major adverse cardiac events (MACE) in patients 
with symptoms or signs suspicious of coronary artery disease (CAD). Studies demonstrated hazard ratios 
for MACE in LGE positive patients ranging from 4.69 to 11.48. 
Conclusion: The use of late gadolinium enhancement as an adjunct to cardiac magnetic resonance (CMR) 
testing has shown to be a valuable asset in predicting major adverse coronary events such as myocardial 
infarction and cardiac death. These events were followed for an accumulative median of 19 months, 
spanning from 6 months to 4.7 years. From the high-quality evidence gathered, LGE was a strong 
predictor of MACE and may have an invaluable future in stratifying risk among patient populations with 
clinical CAD. 
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Abstract 
Background:  Coronary artery disease is the most common type of 
heart disease. CAD encompasses atherosclerosis and arteriosclerosis 
and is the leading cause of death in the United States in both men and 
women. This disease process involves the blood vessels responsible for 
supplying blood to the heart. Arteriosclerosis is described as a 
hardening of the vessels, while atherosclerosis is the obstruction of 
vessels due to genetics and dietary/lifestyle activities. In the long-
term, these abnormalities can lead to myocardial infarction (MI), 
valvular heart disease, chest pain or angina, and heart failure. 
Standard practice of care currently involves the use 
electrocardiogram (ECG), computed tomography (CT), and 
echocardiogram in order to monitor cardiac function. A new emerging 
imaging study, cardiac magnetic resonance with late gadolinium 
enhancement, has shown to be a promising prognostic tool in 
evaluating patient’s risks for major adverse coronary events (MACE). 
CMR is a medical imaging technology for non-invasive 
assessment for the function and structure of the heart. Gadolinium is a 
contrast agent that can be injected during the CMR study that localizes 
in cardiac cicatrix tissue. If the imaging study has a positive result, it 
may lend evidence that cardiac function is below optimal and may put 
patient at risk for MACE in the future.  
Methods:  An exhaustive search of available medical literature was 
performed using the following databases: MEDLINE-OVID, MEDLINE-
Pubmed, and CINAHL-EBSCO Host. Articles were discovered using the 
following terms: MRI, Coronary heart disease, gadolinium, LGE, and 
cicatrix. Relevant articles were assessed for quality using GRADE.  
Results:  Three studies met the inclusion criteria and were included in 
this systematic review. All three of these cohort studies demonstrated 
that the presence of scar tissue, identified by late gadolinium 
enhancement (LGE), had a positive predictive value of major adverse 
cardiac events (MACE) in patients with symptoms or signs suspicious 
of coronary artery disease (CAD). Studies demonstrated hazard ratios 
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for MACE in LGE positive patients ranging from 4.69 to 11.48. 
Conclusion:  The use of late gadolinium enhancement as an adjunct 
to cardiac magnetic resonance (CMR) testing has shown to be a 
valuable asset in predicting major adverse coronary events such as 
myocardial infarction and cardiac death. These events were followed 
for an accumulative median of 19 months, spanning from 6 months to 
4.7 years. From the high-quality evidence gathered, LGE was a strong 
predictor of MACE and may have an invaluable future in stratifying risk 
among patient populations with clinical CAD.  
Keywords:  MRI, coronary heart disease, gadolinium, and cicatrix. 
- 5 -
Table of Contents 
Biography      2 
Abstract      3 
Abstract      4 
Table of Contents    5 
List of Tables     6 
List of Abbreviations   7 
List of Appendices     7 
BACKGROUND 7 
METHODS  8 
RESULTS 9-13
DISCUSSION 13-15
CONCLUSION 15
References 15
Table I. Characteristics of Reviewed Studies 17
 - 6 -  
 
List of Tables 
 
Table I: Quality Assessment of Reviewed Articles 
 
List of Abbreviations 
 
LGE  Late Gadolinium Enhancement 
CAD  Coronary Artery Disease 
MACE  Major Adverse Cardiac Events 
CMR  Cardiac magnetic Resonance  
MI  Myocardial Infarction 
CT  Computed Tomography 
ECG  Electrocardiogram 
 
 
 
  
 - 7 -  
 
Late Gadolinium Enhancement by Cardiac Magnetic Resonance 
Imaging and Major Adverse Coronary Events 
 
BACKGROUND  
Coronary artery disease (CAD) is the most common type of heart disease. CAD 
encompasses atherosclerosis and arteriosclerosis and is the leading cause of death in the 
United States in both men and women.1 Arteriosclerosis is described as a hardening of 
the vessels, while atherosclerosis is the obstruction of vessels due to genetics and dietary 
or lifestyle activities. In the long-term, these abnormalities can lead to myocardial 
infarction (MI), valvular heart disease, chest pain or angina, and heart failure.  
 Standard practice of care currently involves the use electrocardiogram (ECG), 
computed tomography (CT), and echocardiogram in order to monitor cardiac function. A 
new emerging imaging study, cardiac magnetic resonance (CMR) with late gadolinium 
enhancement (LGE), has shown to be a promising prognostic tool in evaluating patient’s 
risks for major adverse coronary events (MACE). 
 The original purpose of LGE was to image cardiac scarring. It was soon 
discovered that it could be used to diagnose specific cardiomyopathies based on the 
pattern of gadolinium absorption in tissue as well as a reliable predictor of future 
cardiomyopathies and MACE. CMR is a medical imaging technology for non-invasive 
assessment for the function and structure of the heart. Gadolinium is a contrast agent that 
can be injected during the CMR study that localizes in cardiac cicatrix tissue.2 If the 
imaging study has a positive result, it may give evidence that cardiac function is below 
optimal which puts the patient at risk for MACE in the future.  
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METHODS 
An exhaustive literature search of available medical literature was performed 
using the following databases: MEDLINE-OVID, MEDLINE-Pubmed, and CINAHL-
EBSCO Host. Articles were discovered using the following terms: MRI, coronary heart 
disease, gadolinium, LGE, and cicatrix. The search was narrowed to use English 
language articles and human trials only. Bibliographies of relevant articles were searched 
for additional sources of information. Relevant articles were assessed for quality using 
Grade of Recommendations, Assessment, Development, and Education (GRADE).  
RESULTS 
An initial search revealed a total of 5 studies. After inclusion criteria was applied, 
3 studies3-5 were included in this systematic review. All 3 of these cohort studies 
demonstrated that the presence of scar tissue, identified by late gadolinium enhancement 
(LGE), had a positive predictive value of major adverse cardiac events (MACE) in 
patients with symptoms or signs suspicious of coronary artery disease (CAD).  
Krittayaphong et al  
The objective of this cohort study3 was to determine the prognosis of patients who 
displayed normal ventricular wall motion with clinical evidence of CAD and the 
possibility of an unrecognized past myocardial infarction. There were 1713 patients who 
were initially gathered to be included in this study. Patients were included in this study if 
they had known or suspected CAD, were more than 30 years old, and CMR showed 
normal wall function.3  
Patients were excluded if they had contraindications for CMR such as pacemakers 
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or internal defibrillators, histories of any myocardial infarction, poor quality images of 
myocardial function, inability to complete the CMR exam as requested, histories of 
revascularization such as angiography, dilated cardiomyopathies, hypertrophic 
cardiomyopathy, myocarditis, cardiac amyloidosis, clinically unstable conditions, and if 
follow-up had failed to be completed. As a result, 565 patients were excluded from the 
study, leaving 1148 patients with normal left ventricular wall motion to be included. 
Average age was 64.6 +/- 11.3 years and had an average follow-up of 955 +/- 542 days.3  
LGE was positive in 104 patients (9%). For patients who had a positive LGE 
study, the statistics for hard cardiac events (ie, death or MI) and MACE had hazard ratios 
of 8.59 (3.23-24.37) and 4.69 (2.28-9.67), respectively. From this data it was found that 
LGE positive patients had an increased risk of cardiovascular events compared to patients 
without a positive study.3  
It was determined that LGE was the best prognostic tool in determining hard 
cardiac events and MACE.  As demonstrated by the following subgroup analysis. Out of 
those 104 patients with positive LGE the major following factors: male gender (63.5%), 
hypercholesterolemia (74%), and hypertension (73.1%).  During the allotted time, 18 
patients had hard cardiac events (ie, death or MI). The subgroups of these 18 patients of 
the LGE positive group are as follows: male gender (HR 1.42, CI 0.56-23.57, P=0.655), 
hypercholesterolemia (HR 0.95, CI 0.37-2.44, P=0.909), and hypertension (HR 0.73, CI 
0.29-1.86, P=0.514). Also during the allotted time, 54 patients experienced MACE. The 
subgroups  of these 54 patients in the LGE positive group are as follows: male gender 
(HR 1.13, CI 0.66-1.93, P=0.655), hypercholesterolemia (HR 1.22, CI 0.69-2.15, 
P=0.487), and hypertension (HR 1.10, CI 0.63-1.93, P=0.73). These subgroup hazard 
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ratios demonstrate that LGE can identify patients at risk for MACE independently of 
other common risk factors.3  
 
The limitations of this study, as described by the authors, are that left ventricular 
hypertrophy and aortic stenosis and were not excluded and may have a relationship with 
LGE. Secondly, abnormal wall motion was assessed visually and not with a quantitative 
tool, lending itself to subjective bias. Lastly, the study did not consider the possibility of 
outside influences having an effect on wall motion abnormality and perfusion 
abnormalities, which could change the clinical outcome.3  
Kwong et al 
The purpose of this study4 was to evaluate the prognostic value of LGE in CMR 
studies due to the fact that 25% of myocardial infarctions go unrecognized by ECG and 
lack any wall motion abnormalities when using CMR. Alternative cardiac function 
imaging studies are needed to more accurately stratify long-term risk in vulnerable 
populations. The initial study population was 221 patients, who were included due to 
possessing signs and symptoms consistent with CAD and had been evaluated by CMR 
imaging.4  
The exclusion criteria included having a history of myocardial infarctions, 
suspected or confirmed myocarditis or cardiomyopathies (including amyloidosis, cardiac 
hemochromatosis or sarcoidosis), any pericardial diseases, unstable angina, class IV heart 
failure, hemodynamic instability, claustrophobia, and metallic hazards. Patients that 
lacked coronary stenosis 2 weeks before CMR were also excluded. As a result of the 
exclusion criteria, 195 patients remained in the study. Follow-up with patients included 
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telephone interviews, contacting the patient’s physician, or accessing medical records. 
Length of follow-up ranged from 6 to 42 months.4  
By the conclusion of the study, 31 (16%) patients had experienced MACE, 
including 17 cardiac deaths, 6 unstable angina events, 5 exacerbations of heart failure, 
and 3 ventricular tachycardia that required the firing of internal cardiac defibrillators. 
Even though other cardiac functioning tests demonstrated a connection with MACE, LGE 
had the most significant association with MACE and long-term cardiac mortality. The 
hard points for this association are as follows: unadjusted HR of 8.29 with a P-value of 
<0.0001, and adjusted HR of 10.9 with a P-value of <0.001.4  
Limitations of this study, as described by the authors, included possible clinician 
bias due to the patient population having to be referred to the study. This restricts the 
ability to immediately apply to the general population for unrecognized myocardial 
infarctions. Secondly, physicians evaluated coronary stenosis utilizing coronary 
angiography imaging at their own discretion, resulting in not every patient having the 
imaging study done and making it impossible to recognize if prognostic significance 
could be maintained.4  
Steel et al 
Subendocardial MI can often go unrecognized by CMR. This study5 suggests that 
LGE is the most sensitive method for recognizing this type of MI and risk stratification of 
patients with known or suspected CAD. There were 264 patients who were initially 
included in the study. Inclusion criteria included patients who were referred to CMR by 
clinicians for signs and symptoms related to chest pain or stable angina.5  
Patients were excluded from the study if there was a history of acute chest pain 
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associated with unstable angina, heart failure, clinically unstable, contraindications for 
vasodilators, and metallic hazards that make them unfit for magnetic imaging. After 
exclusion criteria were applied, 10 patients were dropped from the study due to technical 
problems, leaving 254 patients to be included. Follow-up time ranged from 8 months to 
4.7 years. Follow-up was completed via telephone call, mailed questionnaire, medical 
chart review, or contact with the patient’s physician. There were 49 cardiovascular events 
within the given time frame, which included 12 cardiac deaths, 16 myocardial infarctions, 
19 hospitalizations due to unstable angina, and 2 cases of percutaneous intervention.5  
Based on data obtained from follow-up, it was determined that 156 patients, 
without a history of MI, had positive LGE and resulted in an 11-fold increase in risk for 
cardiac death or MI. The statistics are as follows: HR 11.48 with a P-value of 0.001.  
Limitations of this study, as described by the authors, included possible clinician 
bias due to the patient population having to be referred to the study. Secondly, although 
this study proved that LGE had a significant prognostic factor in established CAD 
patients, further studies are needed to see its applicability to patients with a lower CAD 
prevalence. Lastly, CMR with LGE was not directly compared to other cardiac imaging 
studies such as stress nuclear myocardial perfusion imaging or computed tomography 
angiography and therefore the efficacy in relation to other imaging studies cannot be 
quantified.5  
DISCUSSION 
Using late gadolinium enhancement with cardiac magnetic resonance imaging has 
been shown to be a valuable prognostic tool in understanding the risks that face particular 
patient populations who exhibit clinical signs and symptoms of heart disease. These 3 
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cohort studies3-5 displayed evidence that supported this theory. As stated before, coronary 
heart disease encompasses 2 disease processes called atherosclerosis and arteriosclerosis. 
Arteriosclerosis is the gradual stiffening and narrowing of blood vessels that are brought 
on by lifestyle habits such as smoking and family genetics. Over an extended period of 
time, dietary and lifestyle habits such as smoking and lack of exercise contribute to the 
formation of fatty cholesterol that obstructs coronary vessels that results in 
atherosclerosis, which is type of arteriosclerosis.  
These processes open the door for poor blood perfusion to the heart and set a 
favorable environment for a heart attack or heart failure. In patients who possess such 
risk factors, it’s important to be able to categorize their unique risk of suffering any 
cardiovascular events so that appropriate measures can be implemented to avoid such 
occurrences. LGE has been proven to be even more resourceful that current diagnostic 
studies and tests at assessing patients risk and if put into effect, can change the face of 
cardiology and primary care.4  
Although the evidence from each one of the studies was compelling in it’s own 
right, there are several limitations that need to be taken into consideration. A limitation 
that was stated in all 3 articles3-5 included the fact that the study population was generated 
through physician referrals. Also, the management of the patients were under direct 
supervision of their physicians, meaning that important treatment decisions regarding 
medications, revascularizations, and catheterizations were left to the discretion of the 
provider and is unclear how the LGE study may have played a role in the decision 
making process. Due to the this limitation, these results may only be applicable to the 
patient population whom the physicians felt had more clinically significant cardiac 
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disease processes. Therefore, the applicability of the studies to the general public is still 
unknown and must be further studied. In one study,5 the use of LGE in CMR was tested 
independently from other cardiac functioning tests such as stress myocardial perfusion 
imaging and computed tomography. Therefore, the efficacy cannot be directly compared 
to that of the aforementioned imaging modalities in terms of prognostic value. These 
limitations could be absolved by additional studies with different patient populations. 
  
CONCLUSION 
The use of late gadolinium enhancement (LGE) as an adjunct to computed 
magnetic resonance (CMR) testing has shown to be a valuable asset in predicting major 
adverse coronary events such as myocardial infarction and cardiac death. These events 
were followed for an accumulative median of 19 months, spanning from 6 months to 4.7 
years. From the high-quality evidence gathered, LGE was a strong predictor of MACE 
with HRs ranging from 4.69 to 11.48 and may have an invaluable future in stratifying 
risk among patient populations with clinical CAD.  
As a clinician, LGE imaging could be implemented in patients to look at the 
extent of myocardial infarctions, evaluate cardiac wall motion abnormalities, and 
discover certain scar or fibrotic patterns with cardiomyopathies that may lead to MACE 
in the future. All diagnostic cardiac imaging pathways, including LGE, are considered to 
be cost-effective when being compared to no testing at all. However, more research must 
be completed to further assess the cost-effectiveness of LGE against more standard 
diagnostic modalities.  
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Table I: Quality Assessment of Reviewed Articles 
Study Design 
Downgrade Criteria 
Upgrade 
Criteria 
Quality 
Limitations Indirectness Inconsistency Imprecision Publication bias 
Krittayaphong et 
al3 
Cohort Not serious Not serious Not serious Not serious  Unlikely Very Large 
Magnitude of 
Effecta 
High 
Kwong et al4 Cohort Not Serious Not Serious Not Serious Not Serious Unlikely Very Large 
Magnitude of 
Effectb 
High 
Steel et al5 Cohort Not Seriousb Not Serious Not Serious Not Serious Unlikely Very Large 
Magnitude of 
Effectc 
High 
a HR of 8.59 for MACE and Hard Events (death/MI) 
b HR of 8.29 for MACE (unadjusted) and HR of 10.9 (adjusted) for cardiac mortality 
c HR of 11.48 for death/MI 
 
 
 
